Moderna’s 2Q earnings beat expectations, but it writes off $500 million in expiring Covid shots

Hits: 0

Moderna took a nearly $500 million hit on write-downs for vaccine inventory that has expired or is expected to expire before is can be used. Read More Go To Source

Be the first to comment

Leave a Reply

Your email address will not be published.


*


4 + eleven =